S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Closing prices for crude oil, gold and other commodities
Sell every Stock except ONE (Ad)
2 Important Retail Stock Battles to Watch
Pipeline break spills 45,000 gallons of diesel in Wyoming
Sinema took Wall Street money while killing tax on investors
Sell every Stock except ONE (Ad)
MarketBeat: Week in Review 8/8 - 8/12
Expanded IRS free-file system one step closer in Dems' bill
In Biden's big bill: Climate, health care, deficit reduction
Biden's Plan to Confiscate Your Cash? (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Closing prices for crude oil, gold and other commodities
Sell every Stock except ONE (Ad)
2 Important Retail Stock Battles to Watch
Pipeline break spills 45,000 gallons of diesel in Wyoming
Sinema took Wall Street money while killing tax on investors
Sell every Stock except ONE (Ad)
MarketBeat: Week in Review 8/8 - 8/12
Expanded IRS free-file system one step closer in Dems' bill
In Biden's big bill: Climate, health care, deficit reduction
Biden's Plan to Confiscate Your Cash? (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Closing prices for crude oil, gold and other commodities
Sell every Stock except ONE (Ad)
2 Important Retail Stock Battles to Watch
Pipeline break spills 45,000 gallons of diesel in Wyoming
Sinema took Wall Street money while killing tax on investors
Sell every Stock except ONE (Ad)
MarketBeat: Week in Review 8/8 - 8/12
Expanded IRS free-file system one step closer in Dems' bill
In Biden's big bill: Climate, health care, deficit reduction
Biden's Plan to Confiscate Your Cash? (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Closing prices for crude oil, gold and other commodities
Sell every Stock except ONE (Ad)
2 Important Retail Stock Battles to Watch
Pipeline break spills 45,000 gallons of diesel in Wyoming
Sinema took Wall Street money while killing tax on investors
Sell every Stock except ONE (Ad)
MarketBeat: Week in Review 8/8 - 8/12
Expanded IRS free-file system one step closer in Dems' bill
In Biden's big bill: Climate, health care, deficit reduction
Biden's Plan to Confiscate Your Cash? (Ad)
ETR:AFX

Carl Zeiss Meditec - AFX Stock Forecast, Price & News

€139.60
-1.55 (-1.10%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
€139.00
€141.45
50-Day Range
€105.65
€142.10
52-Week Range
€104.55
€202.00
Volume
62,457 shs
Average Volume
94,405 shs
Market Capitalization
$12.49 billion
P/E Ratio
50.95
Dividend Yield
0.67%
Price Target
€179.25
AFX stock logo

About Carl Zeiss Meditec (ETR:AFX) Stock

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and solutions for the diagnosis and treatment of eye diseases; and systems and consumables for cataract, retinal, and refractive surgeries. It serves practicing ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The Microsurgery segment offers visualization solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, dental and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

Receive AFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Carl Zeiss Meditec and its competitors with MarketBeat's FREE daily newsletter.

AFX Stock News Headlines

CARL ZEISS MEDITEC AG (AFX.MU)
CARL ZEISS MEDITEC AG (AFX.DU)
Carl Zeiss Meditec AG Inhaber-A (AFX.SG)
See More Headlines
Receive AFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Carl Zeiss Meditec and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Diagnostics & Research
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
3,531
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
€177.43
High Stock Price Forecast
€215.00
Low Stock Price Forecast
€146.00
Forecasted Upside/Downside
+28.4%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.73 billion
Cash Flow
€0.10 per share
Book Value
€19.34 per share

Miscellaneous

Free Float
N/A
Market Cap
$12.49 billion
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Justus Felix Wehmer (Age 57)
    CFO & Member of the Management Board
    Comp: $564.5k
  • Mr. Jan Willem de Cler
    Member of Management Board
  • Dr. Markus Weber
    Pres, CEO & Chairman of Management Board
  • Mr. Sebastian Frericks
    Director of Investor Relations
  • Mr. Martin Wiechmann
    Head of the Planetarium Bus. Unit
  • Mr. Mike Wang
    Head of Marketing - Shanghai
  • Mr. Steven C. Schallhorn M.D.
    Chief Medical Officer for Global Ophthalmic Devices
  • Mr. Andrew Chang
    Head of Sales for Ophthalmic Devices & Pres of Carl Zeiss Meditec, Inc.
  • Laurie Ferguson
    Head of Global Communications Ophthalmic Devices
  • Dr. Euan S. Thomson Ph.D. (Age 59)
    Pres of Ophthalmic Devices & Head of the Ophthalmic Devices Strategic Bus. Unit













AFX Stock - Frequently Asked Questions

What is Carl Zeiss Meditec's stock price forecast for 2022?

0 brokerages have issued twelve-month price objectives for Carl Zeiss Meditec's shares. Their AFX share price forecasts range from €146.00 to €215.00. On average, they expect the company's stock price to reach €177.43 in the next year. This suggests a possible upside of 27.1% from the stock's current price.
View analysts price targets for AFX
or view top-rated stocks among Wall Street analysts.

How have AFX shares performed in 2022?

Carl Zeiss Meditec's stock was trading at €184.85 at the beginning of the year. Since then, AFX shares have decreased by 24.5% and is now trading at €139.60.
View the best growth stocks for 2022 here
.

Is Carl Zeiss Meditec a good dividend stock?

Carl Zeiss Meditec (ETR:AFX) pays an annual dividend of €0.90 per share and currently has a dividend yield of 0.67%. The dividend payout ratio is 32.85%. This payout ratio is at a healthy, sustainable level, below 75%.

What other stocks do shareholders of Carl Zeiss Meditec own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Carl Zeiss Meditec investors own include Covestro (1COV), AbbVie (ABBV), AmerisourceBergen (ABC), Allianz (ALV), Daimler (DAI), Gilead Sciences (GILD), Intel (INTC), NVIDIA (NVDA), QUALCOMM (QCOM) and SAP (SAP).

What is Carl Zeiss Meditec's stock symbol?

Carl Zeiss Meditec trades on the ETR under the ticker symbol "AFX."

What is Carl Zeiss Meditec's stock price today?

One share of AFX stock can currently be purchased for approximately €139.60.

How much money does Carl Zeiss Meditec make?

Carl Zeiss Meditec (ETR:AFX) has a market capitalization of $12.49 billion and generates $1.73 billion in revenue each year.

How many employees does Carl Zeiss Meditec have?

The company employs 3,531 workers across the globe.

How can I contact Carl Zeiss Meditec?

Carl Zeiss Meditec's mailing address is Goeschwitzer Strasse 51-52, JENA, 07745, Germany. The official website for the company is www.zeiss.com. The company can be reached via phone at +49-3641-2200.

This page (ETR:AFX) was last updated on 8/13/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.